- Home
- MNKD vs PRA Comparison
MNKD vs PRA Comparison
Compare MNKD & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- PRA
- Stock Information
- Founded
- MNKD 1991
- PRA 1976
- Country
- MNKD United States
- PRA United States
- Employees
- MNKD N/A
- PRA N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- PRA Property-Casualty Insurers
- Sector
- MNKD Health Care
- PRA Finance
- Exchange
- MNKD Nasdaq
- PRA Nasdaq
- Market Cap
- MNKD 1.4B
- PRA 1.2B
- IPO Year
- MNKD 2004
- PRA N/A
- Fundamental
- Price
- MNKD $4.15
- PRA $23.19
- Analyst Decision
- MNKD Strong Buy
- PRA Hold
- Analyst Count
- MNKD 5
- PRA 4
- Target Price
- MNKD $9.40
- PRA $21.00
- AVG Volume (30 Days)
- MNKD 1.9M
- PRA 564.7K
- Earning Date
- MNKD 05-08-2025
- PRA 05-06-2025
- Dividend Yield
- MNKD N/A
- PRA N/A
- EPS Growth
- MNKD 228.27
- PRA N/A
- EPS
- MNKD 0.10
- PRA 0.83
- Revenue
- MNKD $297,595,000.00
- PRA $1,140,267,000.00
- Revenue This Year
- MNKD $14.36
- PRA N/A
- Revenue Next Year
- MNKD $13.36
- PRA $0.57
- P/E Ratio
- MNKD $40.01
- PRA $28.04
- Revenue Growth
- MNKD 32.50
- PRA N/A
- 52 Week Low
- MNKD $4.05
- PRA $10.76
- 52 Week High
- MNKD $7.63
- PRA $23.70
- Technical
- Relative Strength Index (RSI)
- MNKD 37.04
- PRA 66.10
- Support Level
- MNKD $4.07
- PRA $23.04
- Resistance Level
- MNKD $4.25
- PRA $23.22
- Average True Range (ATR)
- MNKD 0.16
- PRA 0.12
- MACD
- MNKD -0.03
- PRA -0.06
- Stochastic Oscillator
- MNKD 12.82
- PRA 67.44
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.